The Pharma Mini MBA Training Course: Transforming Learning into Real-World Industry Impacts (ONLINE EVENT: July 9-11, 2025)
Optimize your leadership role in the competitive pharmaceutical industry with the Pharma Mini MBA. This accelerated, three-day course blends practical management tools with industry-specific case studies to enhance skills and strategic thinking. Gain insights into pharma challenges and technology innovations while earning CPD hours.
Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course" training has been added to ResearchAndMarkets.com's offering.
This intensive three-day course will help you to translate your learning into new behaviours and improvements in your capability and performance and will work through live issues impacting on the industry and on you directly. The individual and group exercises will focus on pharmaceutical/biopharma/generic MBA case studies, and also on your own challenges and examples. The business school case studies will help give the 'feel' of a full MBA and help you understand more about the strategies used in today's pharmaceutical and associated industries.
Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This event has been especially designed to help you transcend these challenges by training you to become equipped to see the bigger picture in all aspects of your role. It will help you build your management skills for the future and prepare you to fulfil your ambitions.
The Pharma Mini MBA accelerated management programme is a distillation of the most valuable parts of an MBA, as applied to the pharmaceutical industry. It will provide you with practical management tools to apply in the workplace, as well as giving a real taste of an MBA course with pharmaceutical case studies from business schools.
Pharmaceutical industry context - business school pharmaceutical case studies on each module
The Pharma Mini MBA is also an invaluable guide to all that is best and most practical on an MBA course - with specific focus on the pharmaceutical sector. It is also of value either to gain the most useful aspects of an MBA or as an MBA taster, providing a foundation of the essential MBA elements to apply directly to your role. The pharmaceutical industry requires employees to focus on successful leadership and business management skills, which this programme is designed to give you.
Who Should Attend:
A 'must-attend' for professionals in the pharmaceutical/biopharma/medical device/animal health industries wishing to develop their business management skills for more senior levels and beyond mere technical ability. It will also help anyone thinking of studying for an MBA who would like an idea of what is involved. It is particularly beneficial to attend with a colleague to maximise the practical learning.
MBA learning style of the programme
The Pharma Mini MBA learning style is 'hands-on' rather than academic. The programme is very practical, without being too theoretical, with industry-relevant case studies drawn from business school cases. The course covers the key areas of an MBA and applies these MBA tools and concepts to the pharmaceutical industry, providing you with a firm foundation of the essential MBA thinking and terminology. Three modules will be covered in just three days of interactive workshops to enhance the value of the course and, to minimise your time away from the office, the programme director also sets optional pre- and post-course work.
Develop your understanding of the key techniques of an MBA to apply to your work
Gain a greater understanding of the pharma industry, its drivers, challenges and opportunities
Hear about the latest strategic technology innovations being used and developed in the pharma industry
Understand what strategic thinking is and how to use strategy tools
Develop your leadership and strategic skills
Become more effective in coping with and managing change in the pharma industry
Explore the benefits and costs of doing an MBA
Take away a Mini MBA toolkit to apply to your job
Discuss and learn from real pharma industry case studies
Pre-course work (sent out to delegates prior to the course)
Diagnostic questionnaire - your strategic competencies
Discussions of diagnostic output/other areas of value
Certifications:
CPD: 18 hours for your records
Certificate of completion
Key Topics Covered:
Day 1
Strategy and strategic challenges in the pharma industry
Strategy and strategic thinking and their importance in the pharma industry
Strategic analysis, planning and implementation
Environmental analysis
Understanding the competitive environment
Strategic options
Applying the MBA toolkit
Stakeholders and their expectations in the pharma industry
Obtaining the value out of strategy in the pharma industry
Day 2
Commercial management and leadership in the pharma industry
New product development and the target product profile
Portfolio management used in the pharma industry
Understanding business performance
The business plan
Diagnosing specific performance problems
Developing strategic alliances and collaborations in the pharma industry
Benefits, costs of doing an MBA and the different routes
The role of leadership
What are the core competencies of effective leaders in pharma?
Leadership vs management
Leadership style and approaches in the pharma industry
Managing innovation in the pharma industry
Innovation approaches currently being adopted along the pharma value chain
Future innovations in pharma and the life science industries
Day 3
Hot topics in market access strategy
Leading and implementing pharma strategy and change
Leading successful change
Diagnosis around change
How to create the conditions for successful change
Why people resist change and how to manage this
Change management including leading a structural reorganisation
Creating a team, department and organisation relevant to today's pharma business needs
Team formation and development
Implementing strategy and change, essentials of planning and managing projects
Project management tools and techniques to use in implementing pharma projects
Applying key project management techniques to pharma projects
Understanding of cultural awareness to work more effectively with pharma colleagues
Practical application/review
Personal development action plan to apply the learning within your own organisation
Revisiting your competency assessment - what has shifted?
Recommended further reading
Practical application of tools (toolkit)
Speakers: Leela Barham Health Economist and Policy Expert Independent (Freelance) BSc (Economics), MSc (Health Economics) Leela Barham is an independent health economist and policy expert working on a freelance basis. This follows 7 years at a specialist economic consulting firm working in a small dedicated health and pharmaceutical team. She has more than 10 years experience in the pharmaceutical industry - both at home and abroad - and has worked for all stakeholders in the health care system ranging from patient organisations, the National Health Service, health insurers, and the pharmaceutical industry. She has particular expertise in public and patient involvement, Patient Access Schemes/risk sharing schemes, the Cancer Drugs Fund, policy on Health Technology Assessment (HTA), and the Pharmaceutical Price Regulation Scheme (PPRS). She regularly writes on hot topics affecting the industry for Pharmaceutical Executive, Pharmaphorum and EyeforPharma and has also written for PharmaTimes, and Pharma Pricing and Reimbursement. She has also had her research published in peer review journals including The Patient and Pharmacoeconomics. Oguz Ozden Strategy Consultant PwC Oguz is a strategy consultant in PwC's Strategy& practice, leading large, complex and international transformations across the Pharma and Life Sciences sector. He has over 10 years of consulting experience in the sector having worked across various functions in Biotech, Pharma and Consumer Health as well as Pharmaceutical Wholesale. Laura Brown Pharmaceutical QA and Training Consultant University of Cardiff Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years' experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including "The Planning of International Drug Development", in the Clinical Research Manual, Euromed and the "Impact of Brexit", RQA Journal 2017. For more information about this training visit https://www.researchandmarkets.com/r/k0ongj
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Errore nel recupero dei dati
Effettua l'accesso per consultare il tuo portafoglio
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
Pharmaceutical Packaging Market Outlook to 2028 - Rising Demand for Biologics, Aging Population and Increased Healthcare Access, Innovations in Drug Delivery Systems
The global pharmaceutical packaging market, valued at USD 131 billion, is experiencing robust growth due to the increasing demand for biologics and expanding pharmaceutical industry. Stemming from factors like a rising geriatric population and stringent safety regulations, innovations in injectables and sustainable packaging are pivotal. Dominant regions like the U.S., Germany, and Japan drive market leadership through advanced technologies. Emphasizing sustainability, regulatory compliance remains a challenge, yet the future outlook is positive, propelled by increased demand for eco-friendly and patient-centric solutions. Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Packaging Market Outlook to 2028" report has been added to Pharmaceutical Packaging Market OverviewThe global pharmaceutical packaging market is valued at USD 131 billion, based on a five-year historical analysis. This market growth is largely driven by the increasing demand for biologics and the expansion of the global pharmaceutical industry. The rising geriatric population and the growing prevalence of chronic diseases have spurred the need for innovative packaging solutions, particularly for injectables and complex drug delivery systems. Additionally, stringent regulations regarding drug safety and the adoption of sustainable packaging materials are influencing the dynamics of the market, with an increased focus on product protection and extended shelf pharmaceutical packaging market is dominated by countries such as the United States, Germany, and Japan. The United States leads due to its robust pharmaceutical industry, high healthcare expenditure, and extensive R&D in drug development. Germany's dominance stems from its highly developed pharmaceutical manufacturing sector, while Japan benefits from strong government support for healthcare innovation and a high aging population. These nations are also pioneers in adopting advanced packaging technologies like anti-counterfeiting solutions and eco-friendly packaging materials, further consolidating their leadership in the global worldwide are imposing stricter packaging standards and labeling requirements to ensure drug safety. In the U.S., the FDA updated its packaging and labeling guidelines in 2023, mandating the inclusion of tamper-evident features on all prescription drugs. These regulations are driving pharmaceutical companies to invest in more advanced packaging solutions that meet the new safety standards, such as child-resistant closures and anti-tampering America leads the market due to the presence of major pharmaceutical companies, advanced healthcare infrastructure, and strong regulatory oversight. Additionally, the growing demand for biologics and injectable drugs has propelled the need for innovative packaging solutions in this region. Europe follows closely, driven by a focus on sustainability and eco-friendly packaging materials, with countries like Germany and the UK contributing significantly. Global Pharmaceutical Packaging Market SegmentationBy Product Type: The global pharmaceutical packaging market is segmented by product type into plastic bottles, blister packs, pre-filled syringes, vials and ampoules, and pouches. Recently, pre-filled syringes have gained a dominant market share under this segment due to the increased demand for biologics and vaccines that require injectable solutions. The convenience and precision dosing offered by pre-filled syringes make them a preferred option in healthcare settings, especially in hospitals and outpatient clinics. Additionally, the rising focus on patient safety and the reduction of contamination risks has further strengthened the growth of this Material Type: The market is segmented by material type into plastics & polymers, glass, aluminum foil, and paper & paperboard. Plastics & polymers dominate the market primarily due to their flexibility, durability, and cost-effectiveness. This material type is widely used for packaging solutions such as blister packs, plastic bottles, and pouches. Moreover, the development of biocompatible and biodegradable plastics for pharmaceutical packaging has further driven demand in this segment. The recyclability of polymer-based packaging also aligns with growing environmental concerns, pushing this material type to the forefront of pharmaceutical Pharmaceutical Packaging Market Growth DriversRising Demand for Biologics: Biologics, which are complex medicines derived from living organisms, have seen increased demand globally. According to data from the World Bank, the global biologics market value in 2023 was estimated at over $300 billion. This growing demand for biologics significantly impacts the pharmaceutical packaging market, as biologics require specialized packaging to maintain stability and efficacy. The demand for injectable biologics, such as insulin, has grown due to the rising prevalence of chronic diseases like diabetes. This has driven the need for sterile packaging solutions and has boosted packaging innovations specifically for Population and Increased Healthcare Access: As of 2023, approximately 10% of the global population is aged 65 and older, as reported by the United Nations. This growing aging demographic is increasing the consumption of pharmaceuticals, particularly in developed countries where healthcare access is widespread. In 2023, healthcare expenditure globally reached $8.5 trillion, according to IMF reports. This increase in healthcare spending, combined with higher pharmaceutical consumption, is leading to higher demand for packaging solutions that cater to senior-friendly designs, such as easy-to-open and tamper-proof in Drug Delivery Systems: Innovations in drug delivery systems, particularly prefilled syringes and self-administered packaging solutions, are driving demand in the pharmaceutical packaging market. By 2023, prefilled syringes accounted for a significant portion of drug delivery packaging, with over 5 billion units produced globally, according to the World Health Organization. This growth stems from the increasing need for more convenient drug delivery methods for patients, particularly in the biologics segment. Packaging companies are developing advanced solutions, such as dual-chamber syringes, to meet the growing demands of this Pharmaceutical Packaging Market ChallengesHigh Regulatory Compliance Costs: Pharmaceutical packaging must comply with stringent regulations globally, which significantly increases costs. As per the U.S. FDA, compliance with packaging and labeling regulations costs the industry over $10 billion annually as of 2023. These regulations ensure the safety, efficacy, and traceability of medicines but also pose challenges for manufacturers in adapting to varying international guidelines. Particularly, biologics and personalized medicine require more complex packaging solutions, which further drive compliance Impact of Packaging Waste: The pharmaceutical industry is responsible for generating millions of tons of packaging waste annually, contributing to environmental concerns. According to the United Nations Environment Programme (UNEP), global plastic packaging waste from the healthcare sector exceeded 5 million tons in 2023. Governments worldwide are tightening regulations around waste management, mandating the use of eco-friendly materials. This poses a significant challenge for pharmaceutical companies, which must balance regulatory compliance with sustainability Pharmaceutical Packaging Market Future OutlookOver the next five years, the global pharmaceutical packaging market is expected to experience substantial growth. This growth will be driven by advancements in drug formulations, a rising focus on patient safety, and the increased adoption of sustainable packaging solutions. Additionally, the rapid expansion of the biologics and biosimilar markets, along with growing demand for sterile and safe packaging options, will contribute to market growth. Further innovation in smart packaging solutions, such as RFID and anti-counterfeiting technologies, will also be a major factor in shaping the future of the Adoption of Sustainable Packaging Solutions: The global shift toward sustainability is pushing pharmaceutical companies to adopt eco-friendly packaging solutions. In 2023, the global market for sustainable packaging solutions in pharmaceuticals was estimated to grow by 12% annually. Biodegradable and recyclable packaging materials are gaining popularity, especially in Europe and North America, where regulations are stringent. The EU, for instance, has introduced mandates that aim for a 50% reduction in single-use plastic packaging in healthcare by 2025, opening up opportunities for manufacturers focusing on Collaborations with Healthcare Providers: Collaborations between pharmaceutical companies and healthcare providers are driving innovation in packaging design to meet the specific needs of various patient populations. In 2023, pharmaceutical companies globally invested over $1 billion in partnerships aimed at developing patient-centric packaging solutions. This collaboration enhances the functionality of packaging, such as easier administration of drugs and improved storage solutions, offering significant opportunities for growth in the pharmaceutical packaging market. Global Pharmaceutical Packaging Market Analysis Growth Drivers Rising Demand for Biologics Aging Population and Increased Healthcare Access Innovations in Drug Delivery Systems Government Initiatives on Healthcare Expenditure Market Challenges High Regulatory Compliance Costs Environmental Impact of Packaging Waste Volatility in Raw Material Prices Complexity in Packaging Design for Sensitive Drugs Opportunities Expansion in Emerging Markets (Latin America, Asia-Pacific) Increasing Adoption of Sustainable Packaging Solutions Technological Advancements in Smart Packaging Strategic Collaborations with Healthcare Providers Trends Surge in Demand for Personalized Medicine Packaging Integration of Track-and-Trace Technologies (IoT, RFID) Growth in Flexible and Unit Dose Packaging Increase in Use of Biodegradable and Recyclable Materials Government Regulations Packaging Standards and Drug Labeling Requirements Anti-Counterfeiting Regulations Waste Management Directives and Packaging Sustainability Pharmaceutical Serialization Laws SWOT Analysis Stakeholder Ecosystem Porters Five Forces Analysis Competitive Ecosystem Analysis Global Pharmaceutical Packaging Market Competitive Analysis Amcor Limited Gerresheimer AG Schott AG Berry Global, Inc. West Pharmaceutical Services, Inc. AptarGroup, Inc. Becton, Dickinson & Co. WestRock Company Nipro Corporation Owens-Illinois, Inc. Mondi Group CCL Industries Inc. Ardagh Group Catalent, Inc. Uhlmann Group For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Cloud Gaming Market Outlook to 2029 with Microsoft Xbox Cloud Gaming Dominating the $35 Billion Market by Ruling More Than Half of the Market Share
Global Cloud Gaming Market: In 2023, valued at USD 3.8 Bn, is projected to reach USD 35 Bn by 2029, driven by 5G connectivity, consumer adoption, and social features. Dominated by Microsoft Xbox Cloud Gaming, key players include Nvidia GeForce Now, Sony, and Amazon Luna. APAC leads due to China, Japan, and South Korea's influence. The market thrives on rising subscription services, mobile gaming trends, and cross-platform compatibility. Challenges include content licensing and scalability issues. Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "Cloud Gaming Market Outlook to 2029" report has been added to 2023, the Global Cloud Gaming Market was valued at USD 3.8 Bn and is forecasted to reach a market size of USD 35 Bn driven by enhancing 5G connectivity, increasing adoption of cloud gaming among consumers, the emergence of Cloud Gaming, and focus on game streaming and social market is highly consolidated with Microsoft Xbox Cloud Gaming dominating the market by ruling more than half of the market share. Other key players in the market include Nvidia GeForce Now, Sony PlayStation Cloud, and Amazon 2021, Microsoft introduced a Clarity Boost feature for Windows users, improving the visual quality of streamed content. The service's performance is contingent on internet speed, with recommendations for optimal experiences set at 9 Mbps download speeds and latency below 60 Cloud Gaming Current Market AnalysisAPAC as dominant region: The Asia Pacific region is dominating the global cloud gaming market owing to the presence of countries like China, Japan, and South Korea, driven by a large and growing gaming population, advanced infrastructure and technology, and high internet penetration and technological adoption. In 2023, the global number of gaming players reached 3.38 billion, APAC region accounts for more than half of all players America as emerging region: North America is the second largest market for cloud gaming globally driven by its popularity of gaming, increasing penetration of high-speed internet, partnerships and collaborations, and advancements in technology. In 2023, the internet penetration rate in the United States was 93.79%. This figure indicates that out of a population of about 331.9 million, around 311.3 million individuals were internet as the dominant country: China is the leading country in the Asia-Pacific cloud gaming market ruling more than half of the market share followed by Japan, and South Korea. The market in China is driven by government support and investment, high penetration of mobile devices, and strong technology infrastructure. In 2023, nearly 99.9% of internet users in China accessed the web via mobile phones. By 2023, the number of mobile internet users in China had reached 1.09 Cloud Gaming Market SegmentationBy Consumer Type: The global cloud gaming market segmentation by consumer type includes enthusiasts and casual gamers. In 2023, casual gamers dominated the market due to their demand for high-quality experiences, such as high-resolution graphics and low latency. They are more likely to invest in premium cloud gaming services and are attracted to exclusive content and advanced Technology: The global cloud gaming market segmentation by technology is classified into video streaming and virtual machines/file streaming. In 2023, video streaming was the dominant technology in the market due to its ability to deliver real-time gaming experiences across various devices, including smartphones, tablets, and smart TVs. Its popularity is driven by advancements in streaming technology that improve performance and reduce Cloud Gaming Market Growth Drivers: Increasing Adoption of Cloud Gaming Among Consumers: Consumers are increasingly adopting and experimenting with cloud gaming services, lured by the capabilities provided by this new technology. By 2029, the number of cloud gaming consumers is anticipated to reach 501.1 Mn users globally. The growth in cloud gaming is attributed to factors such as the proliferation of high-speed internet, the convenience of accessing games without the need for expensive hardware, and the ability to play on various devicesEmergence of Cloud Gaming: The emergence of Cloud Gaming is a significant driver for the growth of the cloud gaming market. By processing data closer to the end-users, Cloud Gaming helps reduce latency, a critical factor for an optimal cloud gaming experience. In 2015, Google Scholar indexed just 720 new papers on Cloud Gaming. By 2023, this number had surged to over 42,700. With the increasing demand for high-performance and low-latency gaming, the adoption of Cloud Gaming is expected to drive substantial growth in the cloud gaming Price of Gaming Hardware: The increasing price of gaming hardware is a significant driver for the growth of the global cloud gaming market, as it offers a more cost-effective alternative for gamers. The average selling price (ASP) of gaming PCs increased by 14.3% in 2022, reaching USD 1,093, compared to USD 956 in 2021. The report attributes this price hike to factors such as higher component costs, supply chain disruptions, and increased demand for high-end gaming Cloud Gaming Market Challenges:Content Licensing and Availability: The limited game library and content availability on cloud gaming platforms compared to traditional gaming platforms can be a significant restraint for the growth of the global cloud gaming market. This lack of content variety stems from the fact that the availability of games on cloud gaming services is contingent upon licensing agreements with game developers and publishers. Exclusive licensing deals or a restricted selection of titles can deter gamers from adopting cloud gaming services due to the reduced appeal caused by the limited content of Economies of Scale: Currently, cloud gaming providers are focusing on improving scalability, as data processing and transmission requirements can be highly demanding. This is because there is almost a 1 to 1 relationship between the resources required to provide an appropriate cloud gaming service and the number of players subscribed to a service. Unless innovative content delivery software is developed, or data center capabilities substantially improve, cloud gaming companies will have to keep investing massive amounts of capital as userbases keep Market TrendsRise of Subscription Services: The cloud gaming market witnesses a surge in subscription services, exemplified by Xbox Game Pass exceeding 33 million subscribers by the end of 2023 and PlayStation Now surpassing 47 million subscribers in 2023. These platforms offer extensive game libraries for a monthly fee, indicating a shift towards subscription-based gaming models. This trend reflects consumer preference for cost-effective access to diverse gaming content, further driving the adoption of subscription services in the cloud gaming Cloud Gaming and Demand for Cross-Platform Compatibility: The proliferation of smartphones and the rollout of 5G networks drive the surge in mobile cloud gaming, a significant trend in the global market. Users enjoy high-quality gaming without powerful hardware, leveraging cloud gaming platforms. Concurrently, cross-platform compatibility gains traction as providers ensure seamless integration across devices. This convergence enhances convenience and accessibility, allowing gamers to transition effortlessly between Topics Covered: 1. Executive Summary1.1 Global Cloud Gaming Market2. Global Overview2.1 Overview of Global Economics2.2 Overview of Global Cloud Gaming Industry2.3 Global Plastics Market3. Global Cloud Gaming Market Overview3.1 Global Cloud Gaming Market Ecosystem3.2 Global Cloud Gaming Market Value Cloud Gaming Market Size (in USD Bn), 2018-20235. Global Cloud Gaming Market (in value %), 2018-20235.1 Global Cloud Gaming Market Segmentation by Region (in value %), 2018-20235.2 Global Cloud Gaming Market Segmentation by Consumer Type (in value%), 2018-20235.3 Global Cloud Gaming Market Segmentation by Technology Type (in value %), 2018-2023 Cloud Gaming Market Competition Landscape6.1 Global Cloud Gaming Market Share Analysis6.2 Global Cloud Gaming Market Heat Map Analysis6.3 Global Cloud Gaming Market Cross Comparison6.4 Global Cloud Gaming Market Comparison Matrix Cloud Gaming Market Dynamics7.1 Global Cloud Gaming Market Growth Drivers7.2 Global Cloud Gaming Market Challenges7.3 Global Cloud Gaming Market Trends7.4 Global Cloud Gaming Market Case Studies7.5 Global Cloud Gaming Market Strategic Initiatives8. Global Cloud Gaming Future Market Size (in value %), 2023-20288.1 Global Cloud Gaming Future Market Segmentation by Region (in value %), 2023-20288.2 Global Cloud Gaming Future Market Segmentation by Consumer Type (in value%), 2023-20288.3 Global Cloud Gaming Future Market Segmentation by Technology Type (in value %), 2023-20289. Analyst RecommendationsA selection of companies mentioned in this report includes, but is not limited to: Nvidia Microsoft Boosteroid Amazon Luna Blacknut Playstation Now Shadow Play For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Business Upturn
an hour ago
- Business Upturn
Odor Control System Market to USD 9.43 Billion by 2032, Owing to Rising Industrial Emissions and Stringent Environmental Regulations
Austin, June 09, 2025 (GLOBE NEWSWIRE) — The odor control system market size was valued at USD 6.13 billion in 2024 and is expected to reach USD 9.43 billion by 2032, growing at a CAGR of 5.54% over the forecast period of 2025-2032. Purchasing power as well as buying patterns of people in the regions mentioned above are factors driving the growth of the global product market in Odor control systems market. With stringent environmental regulations and a growing public awareness related to air quality, industries are adopting advanced odor control systems to reduce unpleasant odors, comply with regulations. The U.S. odor control system market is poised for steady growth, with market size expected to expand from USD 1.07 billion in 2024 to USD 1.70 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.92%. With the newly implemented and heightened local, regional, and federal environmental standards, odor control technologies will need to meet the growing demand for emissions management as municipalities and industries upgrade and expand wastewater treatment facilities. Download PDF Sample of Odor Control System Market @ Key Players: Evoqua Water Technologies LLC (Xylem) DuPont Tholander Ablufttechnik GmbH Veolia Catalytic Products International Advanced Air Technologies, Inc. Anguil Environmental Systems, Inc. Ecolab Durr Group Scotmas Group Ltd. Power & Energy Sector Dominates as Chemical & Petrochemical Drives Fastest Growth in the Odor Control System Market By Type: The Activated Carbon Odor Control segment led the odor control system market, capturing 48.02% of the market share in 2024. This dominance is because activated carbon has a greater capacity to adsorb a wide range of odor-causing molecules, allowing it to perform its work well on various fronts. Because of its durability and ease of maintenance, a major use for FRP is in wastewater treatment, chemical processing, and food manufacturing. Its dynamic capabilities and environmental safety make it a versatile solution for many systems of different designs. The Biological Odor Control segment is witnessing the fastest growth in the odor control system market. This growth is largely the result of the growing transition towards sustainable and environmentally friendly practices. Such systems utilize naturally present microorganisms to biologically degrade odor-forming compounds, specifically for organic waste and wastewater applications. Biological solutions are also garnering attention in industries aspiring to lessen environmental damage due to their low operational costs and no or limited usage of chemicals. By End-Use: In 2024, the Power & Energy segment emerged as the leading end-user in the odor control system market, with over 32% market share. A power plant, gas processing unit, refinery and other similar facilities emit a large number of foul gases and therefore require the best-in-class foul gas control systems. These emissions frequently include volatile organic compounds (VOCs) and sulfur compounds, and they harmful impact on local downstream communities and the environment. This industry is required to meet emission standards and environmental compliance; hence, the odor control systems are essential. The Chemical & Petrochemical sector is the fastest-growing end-use segment in the odor control system market. The industry is characterized by the frequent emission of harmful and odorous gases such as ammonia, sulfur compounds, and VOCs. Depending on environmental and occupational risks, emissions are regulated directly or indirectly through emissions limits imposed by various regulatory bodies. This is partly why facilities are now spending more on advanced odor control technologies to protect the air quality for workers and for communities surrounding facilities. Buy Full Research Report @ North America Emerges as Fastest-Growing Region Driven by Regulatory Pressure and Smart Technologies The Asia Pacific region dominated with a market share of over 45.04% in 2024, driven by rapid industrialization and urbanization. Several East Asia nations, including China, India, Japan among others, have been rapidly expanding their respective wastewater treatment, chemical processing, and food processing sectors, which have been in turn driving the growth of odor control systems, for example the deodorizing equipment & systems, chemicals & consumables & consumables among others, in the regional market. This is supported by strict environmental regulations and a growing concern for air quality, which further drives the market in the region. North America is projected to be the fastest-growing region in the odor control system market. Sustained Demand growth is mainly driven by stringent environmental regulations by agencies like the EPA, which require industries to implement efficient odor Management systems. Furthermore, the adoption of advanced technologies including Internet of Things (IoT) based smell monitoring systems, is improving the efficiency of odor controlling solutions, fueling the growth of the regional market over the coming years. About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
